Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Impact of Prednisone on Semen Parameters and Pregnancy Rates Post Vasectomy Reversal
NCT04788823Phase 4Completed
- Sponsor
- Charitable Union for the Research and Education of Peyronie's Disease
- Start
- Feb 2021
- Primary completion
- Aug 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of prednisone in vasectomy reversal (4 arms), sponsored by Charitable Union for the Research and Education of Peyronie's Disease. Primary endpoints: Impact of Prednisone on semen concentration at 3 years, Impact of prednisone on pregnancy rates at 3 years and 1 more. Started Feb 2021; status: completed.
02
Drugs
prednisone
03
Conditions
vasectomy reversal
Beyond the preview
Go deeper on NCT04788823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04788823.